Short answer
Azenta, Inc. (AZTA) filed its Q1 2026 10-Q quarterly report on May 8, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $145M (up 1.0% year over year) with net income of −$161M.
Q1 2026 key financials · XBRL
- Revenue
- $145M
- +1.0% YoY · −2.6% QoQ
- Net income
- −$161M
- −297.5% YoY · −942.0% QoQ
- Operating margin
- -114.5%
- Gross margin
- 42.8%
- EPS (diluted)
- −$3.49
- −292.1% YoY · −926.5% QoQ
Source: XBRL data from the Azenta, Inc. (AZTA) Q1 2026 10-Q on SEC EDGAR. USD.
Azenta, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- B Medical Systems sale delayed; $63.0M transaction remained subject to financing as of March 31, 2026
- Buyer deposit $9.0M received; remaining $54.0M unpaid
- Provided text excludes quarterly revenue, margins, segment performance, cash flow, and outlook details
Risk Factors
- Acquisition risk: Thelema S.À R.L. financing failure could prevent completion of B Medical Systems acquisition
- Transaction risk: B Medical Systems acquisition remains dependent on buyer financing
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Azenta, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.